Premium
Proteome and cytokine serum profiling to diagnose a mycosis fungoides
Author(s) -
Moshkovskii Sergei A.,
Sokolova Elizaveta E.,
Brattseva Ekaterina V.,
Karpova Maria A.,
Pyatnitskiy Mikhail A.,
Kubanova Anna A.,
Archakov Alexander I.
Publication year - 2011
Publication title -
proteomics – clinical applications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.948
H-Index - 54
eISSN - 1862-8354
pISSN - 1862-8346
DOI - 10.1002/prca.201000165
Subject(s) - mycosis fungoides , cytokine , chemokine , medicine , cxcl10 , psoriasis , immunology , biomarker , multiplex , pathology , biology , lymphoma , inflammation , bioinformatics , biochemistry
Purpose: The aim of this study was to estimate a possibility of mycosis fungoides (MF) diagnostics based on protein profiling in blood serum. Experimental design: We obtained and analysed samples of blood serum from 23 patients with MF, and 29 psoriasis patients and 22 healthy donors as controls. Protein profiling was carried out using SELDI TOF MS SELDI‐TOF and also profiling of 27 cytokines with multiplex immunoassay technology was implemented. Results: MS data analysis of sera did not give satisfactory statistical discrimination between the groups. Antibody‐based cytokine profiling revealed a number of cytokines with a change in their concentrations in both MF and psoriasis (IL‐1Ra, IL‐4, G‐CSF). The C‐X‐C motif chemokine 10 (IP‐10, CXCL10) cytokine had a significantly increased concentration ( p <0,001) in samples from MF patients as compared with the other groups. Conclusions and clinical relevance: IP‐10 may be considered as a promising biomarker for the differentiation between MF and other skin conditions.